When, how, and what cell source for hematopoietic cell transplantation in first complete remission adult acute lymphoblastic leukemia?

@article{Lazarus2012WhenHA,
  title={When, how, and what cell source for hematopoietic cell transplantation in first complete remission adult acute lymphoblastic leukemia?},
  author={Hillard M Lazarus and Anjali S. Advani},
  journal={Hematology. American Society of Hematology. Education Program},
  year={2012},
  volume={2012},
  pages={382-8}
}
Adult acute lymphoblastic leukemia (ALL) is a heterogeneous disease affected by many patient- and disease-related factors, including age, immunologic subtype, and clinical, genetic, and molecular features. Allogeneic hematopoietic cell transplantation (HCT) has occupied an increasing therapeutic role as a result of significant improvements in supportive care and histocompatibility testing. ALL Philadelphia chromosome-negative patients formerly excluded now are considered HCT candidates and… CONTINUE READING